![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2024-06-24/rani-progen-partner-to-co-develop-commercialize-oral-obesity-treatment/9769
https://www.globenewswire.com/news-release/2024/05/14/2881304/0/en/Rani-Therapeutics-to-Participate-in-May-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/09/2878696/0/en/Rani-Therapeutics-to-Present-Clinical-and-Preclinical-Data-on-Oral-Delivery-of-an-Ustekinumab-Biosimilar-via-the-RaniPill-Capsule-at-Digestive-Disease-Week-2024.html
https://www.globenewswire.com/news-release/2024/05/06/2876155/0/en/Rani-Therapeutics-Reports-First-Quarter-2024-Financial-Results-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/15/2847299/0/en/Rani-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/05/2823504/0/en/Rani-Therapeutics-Announces-Positive-Topline-Results-from-Phase-1-Study-of-an-Oral-Anti-Interleukin-12-23-Antibody-RT-111.html
https://www.globenewswire.com//news-release/2023/12/14/2796207/0/en/Rani-Therapeutics-Announces-Preclinical-Pharmacodynamic-Data-on-Transenteric-Delivery-of-GLP-1-Incretin-Triagonist.html
https://www.globenewswire.com//news-release/2023/11/08/2776683/0/en/Rani-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-Provides-Corporate-Update.html
https://www.fiercebiotech.com/biotech/rani-and-sangamo-jettison-staff-offices-and-assets-keep-businesses-afloat-next-year
https://www.globenewswire.com//news-release/2023/11/01/2771720/0/en/Rani-Therapeutics-Announces-Strategic-Program-Prioritization-Expansion-of-Manufacturing-and-Plans-to-Streamline-Business-Operations-to-Support-Near-Term-Value-Drivers-and-Long-Term.html